Smorenburg SM - Search Results

1

Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.

Klerk CP, Smorenburg SM, Büller HR. Klerk CP, et al. Among authors: smorenburg sm. Arch Intern Med. 2003 Sep 8;163(16):1913-21. doi: 10.1001/archinte.163.16.1913. Arch Intern Med. 2003. PMID: 12963564 Review.

2

The effects of unfractionated heparin on survival in patients with malignancy--a systematic review.

Smorenburg SM, Hettiarachchi RJ, Vink R, Büller HR. Smorenburg SM, et al. Thromb Haemost. 1999 Dec;82(6):1600-4. Thromb Haemost. 1999. PMID: 10613641

3

The effect of low molecular weight heparin on survival in patients with advanced malignancy.

Klerk CP, Smorenburg SM, Otten HM, Lensing AW, Prins MH, Piovella F, Prandoni P, Bos MM, Richel DJ, van Tienhoven G, Büller HR. Klerk CP, et al. Among authors: smorenburg sm. J Clin Oncol. 2005 Apr 1;23(10):2130-5. doi: 10.1200/JCO.2005.03.134. Epub 2005 Feb 7. J Clin Oncol. 2005. PMID: 15699479 Clinical Trial.

4

Prophylactic plasma levels of the low molecular weight heparin nadroparin does not affect colon cancer tumor development in mouse liver.

Klerk CP, Niers TM, Brüggemann LW, Smorenburg SM, Richel DJ, Spek CA, Van Noorden CJ. Klerk CP, et al. Among authors: smorenburg sm. Thromb Res. 2010 Mar;125(3):235-8. doi: 10.1016/j.thromres.2009.03.005. Epub 2009 Apr 15. Thromb Res. 2010. PMID: 19371924 No abstract available.

5

In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis.

Smorenburg SM, Vink R, te Lintelo M, Tigchelaar W, Maas A, Büller HR, van Noorden CJ. Smorenburg SM, et al. Clin Exp Metastasis. 1999 Jul;17(5):451-6. doi: 10.1023/a:1006648429914. Clin Exp Metastasis. 1999. PMID: 10651313

6

Screening for cancer in patients with idiopathic venous thromboembolism: the clinical practice.

Otten JM, Smorenburg SM, de Meij MA, van der Schoor CA, Brandjes DP, Büller HR. Otten JM, et al. Among authors: smorenburg sm. Pathophysiol Haemost Thromb. 2002 Mar-Apr;32(2):76-9. doi: 10.1159/000065079. Pathophysiol Haemost Thromb. 2002. PMID: 12214152

7

Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.

Hettiarachchi RJ, Smorenburg SM, Ginsberg J, Levine M, Prins MH, Büller HR. Hettiarachchi RJ, et al. Among authors: smorenburg sm. Thromb Haemost. 1999 Aug;82(2):947-52. Thromb Haemost. 1999. PMID: 10605808 No abstract available.

8

Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation.

Klerk CP, Smorenburg SM, Spek CA, Van Noorden CJ. Klerk CP, et al. Among authors: smorenburg sm. J Cell Mol Med. 2007 May-Jun;11(3):561-8. doi: 10.1111/j.1582-4934.2007.00046.x. J Cell Mol Med. 2007. PMID: 17635646 Free PMC article.

9

The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis.

Smorenburg SM, Vink R, Otten HM, Swaneveld F, Büller HR. Smorenburg SM, et al. Thromb Haemost. 2001 Dec;86(6):1586-7. Thromb Haemost. 2001. PMID: 11776335 Review. No abstract available.

10

Risk assessment and prophylaxis of venous thromboembolism in non-surgical patients: cancer as a risk factor.

Otten HM, Prins MH, Smorenburg SM, Hutten BA. Otten HM, et al. Among authors: smorenburg sm. Haemostasis. 2000;30 Suppl 2:72-6; discussion 63. doi: 10.1159/000054167. Haemostasis. 2000. PMID: 11251345 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters